Covid-19: Three purchasing behaviour trends at molecular labs (Asia-Pacific) Download our latest IVD infographic "Covid-19: Three… In-vitro diagnostics | Molecular Diagnostics (MDx) | Asia | IVD Gateway
[On-demand Webinar] Covid-19 Impact: Molecular Diagnostic (MDx) Market EIU Healthcare zooms in on two of the fastest-growing… Covid-19 testing | In-vitro diagnostics | Molecular Diagnostics (MDx) | Asia | Europe | Global | IVD Gateway | Molecular Diagnostics (MDx)
[On-demand Webinar] Will Covid-19 Accelerate the Next Wave of Adoption of Next-Generation Sequencing (NGS) in Healthcare? EIU Healthcare hosted the “Will Covid-19 Accelerate the… Covid-19 testing | In-vitro diagnostics | Next Generation Sequencing (NGS) | Asia | IVD Gateway
Covid-19 Testing Monitor: More than Seven-fold Increase in Diagnostic Testing Volume in the US, Brazil and India EIU Healthcare has launched the Covid-19 Testing Monitor –… Covid-19 testing | In-vitro diagnostics | Americas | Asia | Europe | Global | IVD Gateway
European IVD Market: Pre- and Post-Covid-19 In our white paper “The European IVD Market Landscape… Covid-19 testing | In-vitro diagnostics | Europe | IVD Gateway
[On-demand Webinar] Beyond Covid-19: A Special on Infectious Disease Testing in Asia EIU Healthcare hosted the “Beyond Covid-19: Preparing for… Covid-19 testing | In-vitro diagnostics | Asia | IVD Gateway
Ageing and the Impact on Japan’s IVD Market In this report “Ageing and the Impact on Japan’s IVD… Centralised Diagnostics (CEDx) | In-vitro diagnostics | Asia | IVD Gateway
Brazil IVD market: Zooming in on high-growth segments As the largest in vitro diagnostic (IVD) market in Latin… Centralised Diagnostics (CEDx) | In-vitro diagnostics | Americas | IVD Gateway
China IVD market: Driving the next leg of growth In this whitepaper “China IVD Market 2019: Driving the… Centralised Diagnostics (CEDx) | In-vitro diagnostics | Asia | IVD Gateway